Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

187

ATC	Name	B/G	Ingredients	Dosage	Form	Price
L04AB04	HUMIRA	BioTech	Adalimumab - 40mg/0.4ml	40mg/0.4ml	Injectable solution	34,045,375 L.L
L04AB04	HYRIMOZ	BioTech	Adalimumab - 40mg/0.4ml	40mg/0.4ml	Injectable solution	52,871,023 L.L
L04AB04	HYRIMOZ	BioTech	Adalimumab - 40mg/0.4ml	40mg/0.4ml	Injectable solution	52,871,023 L.L
L04AB04	HUMIRA	BioTech	Adalimumab - 40mg/0.4ml	40mg/0.4ml	Injectable solution	L.L
L04AB04	ABRILADA	BioTech	Adalimumab - 40mg	40mg	Injectable solution	40,259,574 L.L
L04AB04	ABRILADA	BioTech	Adalimumab - 40mg	40mg	Injectable solution	40,259,574 L.L
L04AB04	ADALIREL	BioTech	Adalimumab - 40mg	40mg	Injectable solution	7,805,376 L.L
L04AB04	HYRIMOZ	BioTech	Adalimumab - 40mg	40mg	Injectable solution	28,611,772 L.L
L04AB04	HYRIMOZ	BioTech	Adalimumab - 40mg	40mg	Injectable solution	28,611,772 L.L
L04AB04	ADALIREL	BioTech	Adalimumab - 40mg	40mg	Injectable solution	L.L
A03E	ACTICARBINE	G	Activated charcoal - 70mg, Papaverine HCl - 14mg		Tablet, coated	311,771 L.L
A07BA01	BIOCARBON	B	Activated charcoal - 250mg	250mg	Tablet	1,361,312 L.L
J05AB01	VICLORIX 800	G	Aciclovir - 800mg	800mg	Tablet	4,321,797 L.L
D06BB03	CYCLOVEX	G	Aciclovir - 50mg/g	50mg/g	Cream	345,560 L.L
D06BB53	ACTI-VIR H	G	Aciclovir - 5%, Hydrocortisone acetate - 1%		Cream	833,182 L.L
D06BB03	CIVAR	G	Aciclovir - 5%	5%	Cream	507,972 L.L
J05AB01	CYCLOVEX	G	Aciclovir - 400mg	400mg	Tablet, scored	2,687,685 L.L
J05AB01	VICLORIX 400	G	Aciclovir - 400mg	400mg	Tablet	3,589,851 L.L
J05AB01	ZOVIRAX IV	B	Aciclovir - 250mg	250mg	Injectable freeze dried substance	2,146,116 L.L
J05AB01	ASIMPLEX	G	Aciclovir - 250mg	250mg	Injectable lyophilised powder for solution	278,175 L.L
J05AB01	LOVRAK-JULPHAR	G	Aciclovir - 250mg	250mg	Injectable lyophilised powder	278,175 L.L
J05AB01	ZOVIRAX	B	Aciclovir - 200mg/5ml	200mg/5ml	Suspension	487,815 L.L
J05AB01	ACTI-VIR	G	Aciclovir - 200mg	200mg	Tablet, scored	1,039,238 L.L
J05AB01	CYCLOVEX	G	Aciclovir - 200mg	200mg	Tablet, scored	1,164,664 L.L
B01AC06	A.S HEART	G	Acetylsalicylic acid - 81mg	81mg	Tablet, enteric coated	148,463 L.L
B01AC06	ASPI-COR	G	Acetylsalicylic acid - 81mg	81mg	Tablet, enteric coated	690,735 L.L
B01AC06	ASPICOT	G	Acetylsalicylic acid - 81mg	81mg	Tablet, enteric coated	353,239 L.L
B01AC06	ASPROTHIN	G	Acetylsalicylic acid - 81mg	81mg	Tablet, enteric coated	148,463 L.L
B01AC06	NU-SEALS	G	Acetylsalicylic acid - 75mg	75mg	Tablet, enteric coated	403,153 L.L
N02BA51	ASPRIVIT	G	Acetylsalicylic acid - 500mg, Caffeine - 50mg, Vitamin B1 - 2mg		Tablet	186,794 L.L

...

187